Stocks · Healthcare · Medical - Diagnostics & Research
RadNet, Inc. RDNT
$69.93 +3.29% Close, Oct 2, 2026 · NASDAQ · Market cap $5.50B
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Net debt is 4.3× EBITDA, a high level of leverage.
- The stock is in an uptrend: above its 200-day average for 44 trading days, with the 50-day average above the 200-day.
- Revenue over the last four quarters was $2.27B, up 18.9% from a year earlier, accelerating from 14.7% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 35%
- FCF growth (TTM, YoY)Bottom 7%
- Revenue growth, 3-year CAGRTop 45%
- Revenue growth accelerationTop 19%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 30%
- Gross marginBottom 10%
- Operating marginTop 36%
- Accruals (lower is better)Top 42%
- Net debt / EBITDA (lower is better)Bottom 17%
- Interest coverTop 41%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 31%
- Free-cash-flow yieldTop 39%
- EBITDA / enterprise valueTop 23%
- Sales / enterprise valueTop 40%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 34%
- 6-month returnTop 34%
- 1-year return vs S&P 500Bottom 35%
- Distance from 52-week highTop 29%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 28%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 41%
- Upside to consensus price targetBottom 7%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 20%
- Maximum drawdown, 3 yearsTop 20%
- Beta vs S&P 500 (lower is better)Top 48%
- Net debt / EBITDA (lower is better)Bottom 17%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 14.7% | 18.9% | ↑ |
| Gross margin | 11.6% | 9.7% | ↓ |
| Operating margin | 3.4% | 4.0% | ↑ |
| FCF margin | 4.0% | -2.6% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 18.9% | 14.7% | ↑ | Top 35% |
| Gross margin | 9.7% | 11.6% | ↓ | Bottom 10% |
| Operating margin | 4.0% | 3.4% | ↑ | Top 36% |
| Net margin | -0.9% | -0.8% | ↓ | — |
| Free-cash-flow margin | -2.6% | 4.0% | ↓ | — |
| Return on invested capital | 1.4% | — | Top 30% | |
| Revenue growth, 3-year CAGR | 12.6% | — | Top 45% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -8.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.32×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.3×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.06%
- Shareholder yield
- -0.06%
- Share count change, 1 year
- +6.3%
- Share count change, 3-year CAGR
- +8.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -11.3%
- Average 2-day reaction, last 8
- +6.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $65.00
- Target vs current price
- -7.0%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 82%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 9, 2026 | +44.0% | +6.8% | +5.5% | +1.8% | — |
| May 11, 2026 | -100.0% | -3.9% | -10.0% | -6.9% | +15.2% |
| Mar 2, 2026 | +21.1% | +7.7% | -13.1% | -19.6% | -22.5% |
| Nov 10, 2025 | -10.3% | +3.2% | -4.0% | -2.7% | -17.6% |
| Aug 11, 2025 | +82.4% | +16.2% | +26.4% | +34.9% | +45.8% |
| May 11, 2025 | -194.1% | +2.3% | +9.7% | +6.0% | -5.0% |
| Feb 27, 2025 | -51.6% | -2.9% | -10.5% | -14.5% | -4.3% |
| Nov 10, 2024 | -13.3% | +19.1% | +9.7% | +8.8% | -13.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 9, 2026 | $0.29 | $0.20 | +44.0% | $622.7M |
| May 11, 2026 | -$0.28 | -$0.14 | -100.0% | $575.6M |
| Mar 2, 2026 | $0.23 | $0.19 | +21.1% | $547.7M |
| Nov 10, 2025 | $0.20 | $0.22 | -10.3% | $522.9M |
| Aug 11, 2025 | $0.31 | $0.17 | +82.4% | $498.2M |
| May 11, 2025 | -$0.50 | -$0.17 | -194.1% | $471.4M |
| Feb 27, 2025 | $0.07 | $0.15 | -51.6% | $477.1M |
| Nov 10, 2024 | $0.13 | $0.15 | -13.3% | $461.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 136.0× | — | — | — |
| EV / EBITDA | 20.6× | — | — | Top 23% |
| EV / Sales | 3.07× | — | — | Top 40% |
| Free-cash-flow yield | -1.06% | — | — | Top 39% |
| Earnings yield | -0.38% | — | — | Top 31% |
P/E over the past five years
Range 32.1× – 442.8× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 44
- 50-day average slope (20 days)
- +5.7%
- 200-day average slope (20 days)
- -0.9%
- Distance from 50-day average
- -3.5%
- Distance from 200-day average
- +6.8%
- RSI (14)
- 43.5
- Relative volume
- 0.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 39.1%
- Volatility vs own 5-year history
- 28th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.08
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -17.2%
- Maximum drawdown, 3 years
- -46.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 6, 2021 | Nov 9, 2022 | -60.2% | 318 days | 299 days (Jan 22, 2024) |
| Nov 11, 2024 | Mar 13, 2025 | -46.8% | 82 days | Not yet recovered |
| Oct 12, 2020 | Oct 30, 2020 | -16.2% | 14 days | 6 days (Nov 9, 2020) |
| Jan 13, 2021 | Feb 18, 2021 | -16.0% | 24 days | 12 days (Mar 8, 2021) |
| Jul 16, 2024 | Aug 5, 2024 | -15.2% | 14 days | 17 days (Aug 28, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $5.50B
- EPS, diluted (TTM)
- -$0.27
- Revenue (TTM)
- $2.27B
- 52-week range
- $50.82 – $85.84
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.32B | $1.43B | $1.62B | $1.83B | $2.04B |
| Gross profit | $191.8M | $165.7M | $221.4M | $249.1M | $90.8M |
| Operating income | $82.6M | $46.4M | $98.7M | $104.6M | $90.8M |
| Net income | $24.7M | $10.7M | $3.0M | $2.8M | -$18.7M |
| EPS (diluted) | $0.46 | $0.17 | $0.05 | $0.04 | -$0.25 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $461.1M | $477.1M | $471.4M | $498.2M | $522.9M | $547.7M | $575.6M | $622.7M |
| Net income | $3.2M | $5.3M | -$37.9M | $14.5M | $5.4M | -$597,000 | -$33.5M | $7.5M |
| EPS (diluted) | $0.04 | $0.07 | -$0.51 | $0.19 | $0.07 | -$0.01 | -$0.43 | $0.10 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $149.5M | $146.4M | $220.9M | $233.0M | $298.8M |
| Capital expenditure | -$220.7M | -$249.4M | -$176.6M | -$188.1M | -$213.3M |
| Free cash flow | -$71.2M | -$103.0M | $44.3M | $45.0M | $85.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $488,000 | $294,000 | $245.8M | $218.4M | $5.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $726.3M
- Total assets
- $4.23B
- Total liabilities
- $2.83B
- Total debt
- $2.18B
- Net debt
- $1.46B
- Shareholders’ equity
- $1.10B
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 9,671,100
- Days to cover
- 11.93
- Change vs previous report
- -2.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 28, 2006
- 1-for-2